Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion description "[Phase II randomized trial comparing high-dose IFN-?2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion evidence source_evidence_literature NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion SIO_000772 23833309 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion wasDerivedFrom befree-2016 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion wasGeneratedBy ECO_0000203 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.